InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,497.20
(
0.00%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
74.75
(
0.91%
)
Bitcoin
68,469.32
(
-0.40%
)
Post# of 118025
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

researcher59

Send PM Follow Ignore
Followers 323
Posts 32397
Boards Moderated 22
Alias Born 12/30/2004

researcher59

Member Level

Re: nelson1234 post# 116929

Tuesday, 10/01/2024 6:27:55 PM

Tuesday, October 01, 2024 6:27:55 PM

Post# of 118025
IART -.67 to 17.50 after analyst lowers price target -

fly -

Integra LifeSciences price target lowered to $16 from $20 at Citi

Citi lowered the firm's price target on Integra LifeSciences to $16 from $20 and keeps a Sell rating on the shares. The firm wonders if the recent rally in medical technology shares can hold heading into the Q3 reports. Citi enters earnings season "cautious," saying Q3 is historically the toughest quarter in MedTech as it brings scrutiny over the 2025 setup and commentary on next year's numbers "could be a governor of price action in the near-term." The firm maintains its top picks on Boston Scientific (BSX), GE HealthCare (GEHC) and Insulet (PODD).
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up